ACRIVON THERAPEUTICS INC. - COMMON STOCK
1.6400
25-四月-25 16:45:00
15 分钟延时
股票
-0.3500
-17.59%
今日范围
1.6100 - 2.0836
ISIN
N/A
来源
NASDAQ
-
07 4月 2025 16:05:00 条件 Nasdaq GlobeNewswire
-
27 3月 2025 17:44:36 条件 Nasdaq GlobeNewswire
-
19 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire
-
05 2月 2025 08:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
13 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16 10月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
11 10月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Cantor Global Healthcare Conference
10 9月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
13 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference
29 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
14 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
24 4月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
10 4月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces $130 Million Private Placement Financing
09 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
28 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >